Sakineh Ebrahimi

1 ta ish

Shahid Beheshti University of Medical Sciences

1. Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers

   Majid Assadi, Seyed Javad Rekabpour, Esmail Jafari +9

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.340322